Verdad Advisers »

C4 Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $288k 109k 2.63

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Capital Management
Soleus Capital Management
Daniel D. Thurber
Two Sigma Investments
Citadel Advisors
Renaissance Technologies
Goldman Sachs Group
Bank of America Corporation
Squadron Capital Management
BlackRock
Silverarc Capital Management

View all funds holding C4 Therapeutics